Archived Newsletters

1. 04.09.26 -- New Editing Modalities Driving Scalable Genomic Medicine 4/9/2026

   04/09/26 Outsourced Pharma Newsletter

2. 04.09.26 -- AI Assesses Passion At CDMOs, But Humans Think Differently 4/9/2026
   04/09/26 Outsourced Pharma Newsletter
3. 04.08.26 -- Does Biotech Need More (Government) Funding — Or A New Growth Model? 4/8/2026
   04/08/26 Outsourced Pharma Newsletter
4. 04.07.26 -- Advancing Next-Generation Biologics: From Cell Line Innovation To Complex Modalities 4/7/2026

   04/07/26 Outsourced Pharma Newsletter

5. 04.07.26 -- How Outsourcing Meets Precision: A Formula For CDMO Interactions 4/7/2026
   04/07/26 Outsourced Pharma Newsletter
6. 04.06.26 -- STREAM Progress: Innovations Powering The Path To The Patient 4/6/2026
   04/06/26 Outsourced Pharma Newsletter
7. 04.06.26 -- In Palm Beach The Focus Is On Biotech (Not President Trump) 4/6/2026
   04/06/26 Outsourced Pharma Newsletter
8. 04.03.26 -- New Podcast Episodes: Regenerative Skin Therapy, Orally Available Biologics, Regulatory Flexibility In CGT, and More 4/3/2026
   04/03/26 Outsourced Pharma Newsletter
9. 04.03.26 -- What If The U.S. Government Stopped Funding Biotech? 4/3/2026
   04/03/26 Outsourced Pharma Newsletter
10. 04.02.26 -- Does Biotech Need More (Government) Funding — Or A New Growth Model? 4/2/2026
    04/02/26 Outsourced Pharma Newsletter